Axtria
Axtria provides cloud software and data analytics solutions to the Life Sciences industry, with products like DataMAx and CustomerIQ.
Secondary Market Price
Secondary Market Price
How Axtria Measures Up
To help you manage your Axtria equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Axtria's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Axtria Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Axtria's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Axtria is a global company that provides cloud software and data analytics solutions, primarily for the life sciences industry, including the pharmaceutical, biotechnology, and medical device sectors. The company’s product suite includes Axtria DataMAx for data management, Axtria SalesIQ for sales operations, Axtria CustomerIQ for customer engagement, and Axtria InsightsMAx.ai for data science. These tools are used to support the product commercialization process. Founded in 2010 by co-founders Jaswinder Chadha and Navdeep Navi Chadha, Axtria has expanded its operations to more than 75 countries. The company reached a market valuation of $1 billion in May 2021 and has raised over $200 million in total funding.
The company is focused on advancing its artificial intelligence capabilities, particularly with its recent announcements regarding Agentic AI for autonomous decision-making and real-time recommendations in life sciences commercial operations. Axtria has also recently published reports on the role of AI in pharmaceutical incentive compensation strategies and the use of generative AI in patient analytics. In one recent case study, the company detailed a partnership with a pharmaceutical firm that resulted in over 20 studies, label expansions, and updated clinical guidelines for a novel therapy. Looking ahead, Axtria has scheduled its Ignite Global event in Hyderabad, India, for February 2026 to discuss enterprise ownership across markets.
- Kedaara Capital
- Bain Capital Tech Opportunities
- Helion Venture Partners
- Gururaj 'Desh' Deshpande
- Amar Sawhney
- Rick Braddock
- Fred Khosravi
- Co-Founder, Jaswinder Chadha
- Co-Founder, Navdeep Chadha
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Axtria worth joining?
Joining a high-growth private company like Axtria can offer significant financial upside through equity compensation. Tools like Prospect can help you model the potential value of your equity to make an informed decision.
What should I do with my Axtria stock?
Managing private company stock involves complex decisions around exercising options, tax planning, and timing the sale of your shares. Using a platform like Prospect can provide personalized, tax-optimized strategies to help you maximize your returns.
Can you sell Axtria stock?
As Axtria is a private company, you can typically sell shares during specific events like tender offers or on secondary marketplaces. Prospect offers tools to help you navigate these sales and determine which shares are the most tax-optimal to sell.
How can I find the value of my Axtria stock?
The value of private stock like Axtria's is determined by its latest 409A valuation and prices on secondary markets, rather than public market data. Platforms such as Prospect provide predictive models and access to secondary market data to help you forecast your equity's potential value.
What is Axtria's equity worth?
Axtria's total equity valuation is determined by private investors during funding rounds and is not publicly disclosed. To understand what your personal equity stake could be worth, you can use Prospect's financial modeling tools to project future value based on various scenarios.
What is Axtria's stock ticker symbol?
Since Axtria is a private company, it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Axtria stock?
Selling Axtria stock is generally possible during company-approved tender offers or on secondary markets, while buying is typically restricted to employees or accredited investors. When opportunities to sell arise, Prospect can help you decide how much to sell and which shares are most tax-efficient.
What is the criteria to buy or invest in Axtria stock?
Investing in a private company like Axtria is typically limited to institutional investors, venture capital firms, and accredited investors. Employees are often able to acquire stock through their equity compensation packages.
